Mandate

Vinge advises Stendörren in connection with issuance of green notes and tender offer

September 13, 2024

Vinge has advised Stendörren Fastigheter AB in connection with its issuance of senior unsecured green notes in an amount of SEK 800 million (within a framework of SEK 1200 million) and its parallel tender offer in respect of its previously issued notes due 2025.

An amount corresponding to the net proceeds from the new notes will be used in accordance with Stendörren’s previously established green financing framework and to repurchase parts of Stendörren’s outstanding senior unsecured notes due 2025.

The notes are intended to be listed on the sustainable bond list of Nasdaq Stockholm. The notes have a tenor of 3.25 years and were issued with a coupon of STIBOR 3m + 290 basis points.

Nordea Bank Abp, Skandinaviska Enskilda Banken AB (publ) and Swedbank AB (publ) acted as joint bookrunners and dealer managers in the transaction.

Vinge’s team consisted of Mikael Ståhl, Lionardo Ojeda, August Ahlin and Rebecka Margolin.

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026